Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Bacteriol ; 191(16): 5232-9, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19542286

ABSTRACT

Recently, cholesterol was identified as a physiologically important nutrient for Mycobacterium tuberculosis survival in chronically infected mice. However, it remained unclear precisely when cholesterol is available to the bacterium and what additional bacterial functions are required for its metabolism. Here, we show that the igr locus, which we previously found to be essential for intracellular growth and virulence of M. tuberculosis, is required for cholesterol metabolism. While igr-deficient strains grow identically to the wild type in the presence of short- and long-chain fatty acids, the growth of these bacteria is completely inhibited in the presence of cholesterol. Interestingly, this mutant is still able to respire under cholesterol-dependent growth inhibition, suggesting that the bacteria can metabolize other carbon sources during cholesterol toxicity. Consistent with this hypothesis, we found that the growth-inhibitory effect of cholesterol in vitro depends on cholesterol import, as mutation of the mce4 sterol uptake system partially suppresses this effect. In addition, the Delta igr mutant growth defect during the early phase of disease is completely suppressed by mutating mce4, implicating cholesterol intoxication as the primary mechanism of attenuation. We conclude that M. tuberculosis metabolizes cholesterol throughout infection.


Subject(s)
Bacterial Proteins/physiology , Cholesterol/metabolism , Mycobacterium tuberculosis/growth & development , Mycobacterium tuberculosis/genetics , Adenosine Triphosphate/metabolism , Animals , Bacterial Proteins/genetics , Cholesterol/pharmacology , Female , Gene Expression Regulation, Bacterial/drug effects , Gene Expression Regulation, Bacterial/genetics , Mice , Mice, Inbred BALB C , Mutation , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/metabolism
2.
Nat Med ; 15(2): 211-4, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19182798

ABSTRACT

Few tools exist to assess replication of chronic pathogens during infection. This has been a considerable barrier to understanding latent tuberculosis, and efforts to develop new therapies generally assume that the bacteria are very slowly replicating or nonreplicating during latency. To monitor Mycobacterium tuberculosis replication within hosts, we exploit an unstable plasmid that is lost at a steady, quantifiable rate from dividing cells in the absence of antibiotic selection. By applying a mathematical model, we calculate bacterial growth and death rates during infection of mice. We show that during chronic infection, the cumulative bacterial burden-enumerating total live, dead and removed organisms encountered by the mouse lung-is substantially higher than estimates from colony-forming units. Our data show that M. tuberculosis replicates throughout the course of chronic infection of mice and is restrained by the host immune system. This approach may also shed light on the replication dynamics of other chronic pathogens.


Subject(s)
Mycobacterium tuberculosis/growth & development , Tuberculosis/microbiology , Animals , Base Sequence , Colony Count, Microbial , DNA Primers , Mice , Mice, Inbred C57BL , Plasmids , Polymerase Chain Reaction , Tuberculosis/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...